Stock Evaluator: Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. ADGM
$0.38
0.00
1.01%
July 31, 2026 4:00:00 PM
EST
Volume: 64,849
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Financial Summary
| Share Statistics | ADGM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $8.4 | $337.2 | 6% |
|
| Shares Out (Mil) | 22.2 | 41.9 | 32% |
|
| Institutional Ownership | 88.0% | 77.8% | 56% |
|
| Float (Mil) | 6.1 | 34.7 | 14% |
|
| Beta | -0.19 | 0.85 | 3% |
|
| Avg Daily Volume (000s) | 100 | 278 | 36% |
|
| Price Change (52-week) |
(72.4%) | 58.7% | 9% |
|
| Growth | ADGM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 11.4% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (16.3%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 3 | |
| Current EPS | ($0.270) | ($0.980) | ($1.350) | |
| Month Ago EPS | ($0.270) | ($0.980) | ($1.350) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.305) | ($1.265) | ($1.695) | |
| Year/Year Chg | (14.3%) | (35.2%) | 2.9% | |
| Financials | ADGM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $152 | na |
|
| Net Income (TTM) (Mil) | ($24) | ($10) | 22% |
|
| EPS (TTM) | ($1.333) | ($0.500) | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($16) | ($2) | 16% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $24 | $22 | 34% |
|
| Enterprise Value (Q1) (Mil) | $24 | $304 | 12% |
|
| Valuation | ADGM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.46 | 2.80 | 38% |
|
| P/E | na | 31.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | ADGM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.1% | na |
|
| Net Margin | na | (7.3%) | na |
|
| ROA | (60.4%) | (13.7%) | 10% |
|
| ROE | (268.9%) | (15.8%) | 3% |
|
| Liabilities to Assets | 85.4% | 44.7% | 79% |
|
| F-Score | 3 | 4 | 19% |
|
Adagio Medical Holdings, Inc. did not pass any screens on 7/31/2026.
